Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
2.750
-0.030 (-1.08%)
Dec 20, 2024, 4:00 PM EST - Market closed
Puma Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 23.24 | 21.59 | 0 | -29.13 | -60 | -75.6 | Upgrade
|
| Depreciation & Amortization | 11.57 | 11.52 | 9.84 | 11.31 | 10.03 | 8.08 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0 | 0 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.63 | 7 | - | - | 1.18 | Upgrade
|
| Stock-Based Compensation | 8.93 | 10.25 | 11.83 | 32.63 | 36.58 | 57.33 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.25 | 0.88 | - | -1 | 1 | - | Upgrade
|
| Other Operating Activities | - | - | - | 8.15 | - | 8.1 | Upgrade
|
| Change in Accounts Receivable | -25.92 | -8.37 | -7.82 | -5.98 | 2.35 | -8.12 | Upgrade
|
| Change in Inventory | 3.01 | -2.55 | 2.58 | -3.66 | -0.28 | -0.55 | Upgrade
|
| Change in Accounts Payable | 2.45 | 0.45 | -4.73 | -0.9 | -7.11 | -1.53 | Upgrade
|
| Change in Other Net Operating Assets | 10.24 | -7.38 | -34.52 | 9.23 | 18.2 | 33.48 | Upgrade
|
| Operating Cash Flow | 33.77 | 27.01 | -15.83 | 20.65 | 0.77 | 22.38 | Upgrade
|
| Operating Cash Flow Growth | 39.32% | - | - | 2571.41% | -96.55% | - | Upgrade
|
| Capital Expenditures | -0.09 | -0.14 | -7 | - | -0.05 | -0.31 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -12.5 | - | - | -10 | - | Upgrade
|
| Investment in Securities | -26.2 | -6.49 | 14.1 | -10.88 | 43.45 | 5.47 | Upgrade
|
| Investing Cash Flow | -26.29 | -19.13 | 7.1 | -10.88 | 33.4 | 5.16 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 98.5 | 8.44 | 25 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -100 | -8.44 | -80 | Upgrade
|
| Net Debt Issued (Repaid) | -22.22 | - | - | -1.5 | - | -55 | Upgrade
|
| Issuance of Common Stock | 0.15 | - | 12.5 | - | 0.07 | 1.35 | Upgrade
|
| Other Financing Activities | -0.45 | - | -0.28 | -30.43 | -10 | -13.42 | Upgrade
|
| Financing Cash Flow | -22.52 | - | 12.22 | -31.93 | -9.93 | -67.07 | Upgrade
|
| Net Cash Flow | -15.04 | 7.88 | 3.5 | -22.16 | 24.24 | -39.53 | Upgrade
|
| Free Cash Flow | 33.68 | 26.87 | -22.83 | 20.65 | 0.73 | 22.07 | Upgrade
|
| Free Cash Flow Growth | 96.48% | - | - | 2740.44% | -96.71% | - | Upgrade
|
| Free Cash Flow Margin | 13.83% | 11.40% | -10.01% | 8.16% | 0.32% | 8.11% | Upgrade
|
| Free Cash Flow Per Share | 0.69 | 0.57 | -0.51 | 0.51 | 0.02 | 0.57 | Upgrade
|
| Cash Interest Paid | 11.39 | 11.63 | 10.32 | 10.34 | 9.7 | 11.74 | Upgrade
|
| Cash Income Tax Paid | 1.42 | 0.74 | 0.38 | 0.32 | 0.21 | 0.05 | Upgrade
|
| Levered Free Cash Flow | 32.7 | 1.79 | -2.59 | 8.08 | -17.23 | 36.08 | Upgrade
|
| Unlevered Free Cash Flow | 40.94 | 10.12 | 4.66 | 16.08 | -8.45 | 45.46 | Upgrade
|
| Change in Net Working Capital | 0.12 | 19.8 | 27.96 | -3.97 | -10.56 | -4.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.